U.S., April 3 -- ClinicalTrials.gov registry received information related to the study (NCT06906198) titled 'Pharmacokinetics of VVN461 Ophthalmic Solution' on Dec. 03, 2024.
Brief Summary: This is a single-center, double-masked, randomized, vehicle-controlled study conducted in China in adult healthy subjects
Study Start Date: March 01, 2023
Study Type: INTERVENTIONAL
Condition:
Healthy Volunteers
Intervention:
DRUG: VVN461 Ophthalmic Solution 1.0%
VVN461, 1.0%
DRUG: VVN461 Ophthalmic Solution 0.5%
VVN461, 0.5%
DRUG: VVN461 Ophthalmic Solution 0.25%
VVN461, 0.25%
DRUG: VVN461 Ophthalmic Solution Placebo
Vehicle
Recruitment Status: COMPLETED
Sponsor: VivaVision Biotech, Inc
Published by HT Digital Content Services with perm...